Overview and Practical Implementation Guidelines
Executive Overview of SFDA Labeling Standards & Prohibited Claims
The Saudi Food and Drug Authority (SFDA) enforces rigorous packaging and labeling governance under technical standard SFDA.FD 58 and GSO 9 for prepackaged foods. Artwork discrepancies represent over 60% of technical rejections during product registration and customs port inspections. Common triggers include unapproved therapeutic claims, omission of mandatory bilingual Arabic/English declarations, absent allergen alerts, and incorrect nutrient reference values.
To audit your product artwork and guarantee complete conformity prior to mass printing, consult with GNSCO Regulatory & Artwork Audit Specialists to safeguard your supply chain against border delays.
Mandatory Components for Compliant Supplement Artwork
- Mandatory Arabic Typography: All essential disclosures (product identity, full ingredient list, directions for use, precautions, manufacturer details) must appear in prominent, legible Arabic.
- Standardized Supplement Facts Panel: Present active nutrient concentrations per recommended serving alongside percentage daily values (%DV) aligned with Saudi dietary guidelines.
- Prominent Allergen Disclosures: Explicitly highlight recognized allergens (soy, gluten, dairy, tree nuts, shellfish) in bold font immediately beneath the ingredient list.
- Zero Disease Mitigation Claims: Prohibit all claims asserting the diagnosis, cure, treatment, or prevention of chronic or acute medical conditions.
1. Regulatory Claims Matrix: Permitted vs Strictly Prohibited Labeling Statements
The SFDA enforces a clear legal boundary between lawful structure/function claims and prohibited medicinal assertions:
| Health Category | Permitted Structure/Function Claims | Strictly Prohibited Medicinal Claims | Regulatory Rationale |
|---|---|---|---|
| Bone & Joint Health | "Calcium and Vitamin D contribute to the maintenance of normal bones and teeth." | "Cures osteoporosis, eliminates arthritis pain, and regenerates cartilage." | Supplements support physiological health; they do not treat degenerative bone pathology. |
| Immune Function | "Zinc and Vitamin C contribute to the normal function of the immune system." | "Protects against viral influenza, covid infections, and bacterial disease." | Prevents consumer deception regarding pharmacological anti-infective properties. |
| Cardiovascular Support | "EPA and DHA omega-3 fatty acids contribute to the normal function of the heart." | "Lowers blood pressure, eliminates arterial plaques, and prevents heart attacks." | Cardiovascular interventions require physician prescription and clinical trial validation. |
| Metabolism & Weight | "Chromium contributes to the maintenance of normal blood glucose levels." | "Burns visceral fat, guarantees rapid weight loss, and replaces diabetes medications." | Strict ban on deceptive metabolic and slimming claims carrying health risks. |
2. Most Prevalent Artwork Errors & Remediation Strategies
Historical evaluation data reveals recurring pitfalls in draft supplement artwork:
- Omission of Mandatory Advisory Statements: Failing to include the statutory phrase: "Food supplements should not be used as a substitute for a varied and balanced diet" and "Consult a healthcare professional prior to use if pregnant or nursing."
- Poor Machine Translation: Relying on automated translation tools that produce distorted botanical terms, resulting in mismatches with registered technical dossiers.
- Serving Size Inconsistencies: Declaring a serving size in the Supplement Facts table that conflicts with the dosage instructions stated in the narrative directions.
- Missing Local Agent Identification: Neglecting to declare the licensed Saudi importer, commercial registration number, and corporate address on the primary label.
Pre-Press Risk Warning: Never Print Before SFDA Digital Approval
Printing commercial packaging before securing official artwork sign-off on the GHAD portal represents an existential financial risk. Saudi customs officers reject consignments exhibiting even minor 1% discrepancies between physical artwork and registered digital files.
3. Specialized Mandatory Warnings for Vulnerable Consumer Demographics
Depending on formulation parameters, specific statutory warnings must be displayed prominently:
- Caffeine & Energy Formulations: "Contains caffeine. Not recommended for children, pregnant or lactating women, or individuals sensitive to caffeine."
- High-Potency Iron Supplements: "Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep out of reach of children."
- Artificial Sweeteners: Explicitly state the sweetener type (e.g. Aspartame, Sucralose) with the mandatory notice: "Contains a source of phenylalanine" where applicable.
Need to apply this to your facility?
Share the activity, city and current stage, and we can help define an appropriate work scope.
Explore supplement development services